back to the Council of Europe internet portal
 
 
Social cohesion
Public health
Asbestos
Cosmetic products
Flavouring substances
Food contact
Links
Mission Statement
Nutrition food consumer health
Pesticides
Pharma and Medicine
Publications
Seminar Pharmacy

Seminar programme

 
"THE PHARMACIST AT THE CROSSROADS OF NEW HEALTH RISKS: AN INDISPENSABLE PARTNER FOR THEIR MANAGEMENT!"
 
COUNCIL OF EUROPE, STRASBOURG, FRANCE
WEDNESDAY 20 - FRIDAY 22 OCTOBER 1999
 
 PROGRAMME
 
20 OCTOBER 1999 (First day)

8:15    Welcome and distribution of documents
 
9:15    Opening address: Mr. Hans Christian KRÜGER, Deputy Secretary General of the Council of Europe
 
9:30    Introductory address: Ms Christiane d'AGATA, Chef du Département "Accidents des produits de santé", Agence Française de Sécurité Sanitaire des Produits de Santé (France), on behalf of the Committee of Experts on Pharmaceutical Questions, Council of Europe
 
9:45    Speech by Mr Kees de JONCHEERE, Regional Adviser for Pharmaceuticals, World Health Organization, Regional Office for Europe: "The pharmacist’s role in the framework of the health promotion"
 
10:00    Speech by Dr William J. HUNTER, Director of Public Health and Safety at Work, DG V, European Commission: "The influence of the European Union policy on pharmaceutical products"
 
10:15    Coffee break
 
10:45 "Introduction to the concept of health security":
Mr Didier TABUTEAU
Member of the Conseil d'Etat
Former Director of the Medicines Agency (France)
 
11:15 Theme I: "Health challenges of the 21st century for the pharmacist":
Dr Peter KIELGAST
President of the International Pharmaceutical Federation (FIP) (Denmark)
 
Chair: Dr Ulrich GLEIM
(Committee of Experts on Pharmaceutical questions) (Germany)
Rapporteurs: Dr. Christian KALCHER, Ms Joëlle MEUNIER
(Committee of Experts on Pharmaceutical questions) (Austria, Belgium)
 
11.45   Questions by participants
 
12:00   Lunch
 
13:30   Round table on the following subjects:

1) Ensuring the Safety of New Therapies, such as Cell and Genetic Therapies (15 minutes talk):
Dr Elwyn GRIFFITHS, Quality Assurance and Safety of Biologicals, Department of Vaccines and Biologicals, World Health Organization, Geneva (Switzerland)

2) Iatrogenic effects of pharmacotherapy: the pharmacist’s contribution to risk management (15 minutes talk):
Prof. Jean CALOP, Professor of Clinical Pharmacy, UFR of Pharmacy, Grenoble; Hospital pharmacist, Head of Service, CHU, Grenoble (France)

3) The counterfeiting of pharmaceuticals: containing the risks (15 minutes talk):
Dr Dietrich SCHNÄDELBACH, former Chairman of the European
Pharmacopoeia Commission (Germany)

4) Self-medication: the added value of the pharmacist (15 minutes talk):
Mr Thierry ROISIN (Pharmacy Inspector) (Belgium)
 
14:30 Discussion at round table and questions by participants
 
15:00 Coffee break
 
15:30 Workshops, under the topics:

1) Pharmacists’ contribution to a greater safety of new therapies, such as cell and genetic therapies

2) Iatrogenic effects of pharmacotherapy: the pharmacist’s contribution to risk management
 
3) The counterfeiting of pharmaceuticals: containing the risks
 
4) Self-medication: the added value of the pharmacist

17:00 Drafting of the conclusions for each workshop by the leaders and rapporteurs
 

18:00 Drafting session of all the workshops’ general conclusions on Theme I

21 OCTOBER 1999 (Second day)

9:00      Presentation of the workshops’ conclusions, whether by the rapporteurs, or by the leaders, presided over by the Chair of the first day session
 
10:00    Theme II: "The health challenges of New Information Technologies: risks and benefits for pharmacists, patients and society":
Mr Lutz TISCH
Head of the Legal Section
Federal Union of German Asssociations of Pharmacists
Chair: Mrs Josée HANSEN
(Committee of Experts on Pharmaceutical questions) (The Netherlands)
Rapporteurs: Dr. Christian KALCHER, Ms Joëlle MEUNIER
(Committee of Experts on Pharmaceutical questions) (Austria, Belgium)
 
10:30   Coffee break
 
11:00   Round table session on the following topics:

1)   Problems with the selling of medicines by INTERNET (15 minutes technical presentation, 15 minutes talk):
Mrs Kirsten MYHR, Adviser, Norwegian Board of Health (Norway)
 
2) Professional networks: inclusion of pharmacists; access to patient records; confidentiality and data protection; pharmaceutical care (15 minutes technical presentation, 15 minutes talk):
Mr Ian SHEPHERD, Head of Information Technology Policy Unit, Royal Pharmaceutical Society of Great Britain (United Kingdom)

3) Electronic transmission of prescriptions; problems: checking validity; remote distribution; retaining the patient’s right to choose a pharmacy; avoiding fraud (15 minutes talk):
Dr. Frank DIENER, Director of the Department for Economics and Health Policy, Federal Union of German Associations of Pharmacists

4) How to get the most from new information technologies for patients and pharmacists (15 minutes talk):
Dr. Johan J. de GIER, Scientific consultant, Health Base Foundation (The Netherlands)

12:30 Discussion at round table and questions by participants
 
13:00 Lunch
 
15:00 Workshops under the topics:

1) How to face up to the problems with the selling of medicines via INTERNET?
 
2) Pharmacists as part of professional networks: what are the issues?
 
3) How to confront the problems of electronic transmission of prescriptions?
 
4) How should pharmacists take advantage of the potential of new information technologies for the benefit of the patient?

17:00 Drafting of the conclusions for each workshop by the leaders and rapporteurs
 
18:00 Drafting session of all the workshops’ general conclusions on Theme II

20:00 Official dinner offered by the Organising Committee

22 OCTOBER 1999 (Third day)

9:00   Presentation of workshops’ conclusions, whether by the rapporteurs, or by the leaders, presided over by the Chair of the second day session
 
10:00   Theme III: "New risks and new information technologies: will the pharmacist add value?"
Dr Michael ASCIAK
MP (Malta) - General Practitioner
Member of the Parliamentary Assembly of the Council of Europe
 
Other speakers:
Economist of health: Dr. Willy OGGIER, Gesundheitsökonomische Beratungen (Switzerland)
 
Representative of sick insurance company: Dr Josepha A. M. HULSHOF, Head of Department of Therapeutic Services, Health Insurance Council (The Netherlands)
 
Chair of pharmaceutical society: Mr Pedro CAPILLA, President of the General Council of Pharmacists Societies (Spain)
Chair: Mr Paul DIETSCHY
(Chairman of the Committee of Experts on Pharmaceutical questions) (Switzerland)
Rapporteur: Mrs Jeannette HOWE
(Committee of Experts on Pharmaceutical questions) (United Kingdom)

11:00   Coffee break

11:20     Questions by participants
 
11:35   Round Table: Debate (possibly with participants)
 
12:45 Closing speech:
Mr Paul J. DIETSCHY (Switzerland)
(Chairman of the Committee of Experts on Pharmaceutical questions)
 
*
ORGANISING COMMITTEE
 
 
Ms Christiane D'AGATA (CHAIR, France))
Mrs Eulalia BELENDEZ (Spain)
Mr. Paul J. DIETSCHY (Switzerland)
Mrs Piedad FERRE(Spain)
Mrs Gabrielle GARDETTE (Switzerland)
Mrs Jeannette A. HOWE (United Kingdom)
Ms Joëlle MEUNIER (Belgium)
 
Mrs Giulia PODESTÀ LE POITTEVIN (Secretariat)
Dr Angel RUIZ DE VALBUENA (Secretariat)